Bioxytran, Inc. Files Q1 2025 10-Q
Ticker: BIXT · Form: 10-Q · Filed: May 15, 2025 · CIK: 1445815
| Field | Detail |
|---|---|
| Company | Bioxytran, Inc (BIXT) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, company-filing
Related Tickers: BIXT
TL;DR
BIOXYTRAN (BIXT) filed its Q1 2025 10-Q. Formerly U.S. Rare Earth Minerals.
AI Summary
Bioxytran, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as U.S. Rare Earth Minerals, Inc., is in the pharmaceutical preparations sector. Its principal executive offices are located in Needham, Massachusetts.
Why It Matters
This filing provides investors with the latest financial and operational updates for Bioxytran, Inc. during the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing with no immediate red flags or significant new information presented.
Key Numbers
- 20250331 — Period End Date (The end of the reporting quarter.)
- 20250515 — Filing Date (The date the report was submitted to the SEC.)
Key Players & Entities
- BIOXYTRAN, INC (company) — Filer
- U.S. RARE EARTH MINERALS, INC. (company) — Former company name
- Needham, MA (location) — Business address city and state
- 20250331 (date) — Period of report
- 20250515 (date) — Filing date
FAQ
What is Bioxytran, Inc.'s primary business sector?
Bioxytran, Inc. is in the Pharmaceutical Preparations sector, SIC code 2834.
When was Bioxytran, Inc. previously known by another name?
The company was formerly known as U.S. Rare Earth Minerals, Inc., with a name change date of 20181005.
Where is Bioxytran, Inc. located?
The company's business and mailing address is in Needham, MA.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
What is the SEC file number for Bioxytran, Inc.?
The SEC file number for Bioxytran, Inc. is 001-35027.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding BIOXYTRAN, INC (BIXT).